Plus de 40 ans d’expérience à votre service

Tel. : 01 45 33 67 17 / E-mail :

Stock épuisé.
En rupture de stock
Quantité minimum d'achat
La quantité minimum d'achat n'est pas atteinte



0.5 mg

Ref. YIF-LF-P0051
AB Frontier

photos non contractuelles

Neuf 321.00 H.T.


Alerte réapprovisionnement
Recevez une alerte par email dès que votre choix sera de retour en stock
Votre e-mail*:

Détails Produit

Product Description: beta-amyloid (Abeta) peptides result from the proteolytic cleavage of beta-amyloid precursor protein (APP) which is encoded by a gene located on chromosome 21. Abeta is produced by two proteases (beta- and gamma- secretase) and has vary forms (39- and 43-mer peptides). Abeta40 and Abeta42 peptides are major constituents of the plaques and tangles that occur in Alzheimer’s disease(AD). Abeta42 plays a critical role in the pathogenesis of AD since its aggregative ability and neurotoxicity are much greater than these of Abeta40. Abeta42 oligomers initially formed as a seed accelerate the aggregation of Abeta40 to form the amyloid plaques that eventually lead to the neurodegeneration (amyloid cascade hypothesis). Abeta40 also serves as an antioxidant molecule by quenching metal ions and inhibiting metal-mediated oxygen radical generation.

Alternate Names/Synonyms: A4; APP; beta-APP42

Product type: Protein

Source / Host: E. coli

Species Crossreactivity: Yeast

SBiological Activity: 9.7U/mg (One unit will cause a DeltaA650 of 1.0 in 1 min at 25°C in the insulin reduction assay)

Purity: >95% (SDS-PAGE)

Concentration: 1 mg/ml

Formulation: Liquid in 20mM HEPES, pH 7.0, 10% Glycerol.

Handling Advice: Avoid freeze/thaw cycles.

Short Term Storage: -20°C

Long Term Storage: -80°C

Shipping: DRY ICE

Use & Stability:

Lien vers la Fiche Technique